• Esbriet (Pirfenidone)

  Esbriet Enables Stable Lung Function for 2 Years in Patients with IPF

  Posted by Pulmonary Fibrosis News Moderator on September 21, 2018 at 1:30 pm

  Real world data collected in a recent study shows that treatment of IPF patients with Esbriet leads to stable lung function over two years. Click here to read more.

  What do you think about this news?

  replied 6 years, 2 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply